![Michael Schönhofen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Schönhofen
Corporate Officer/Principal at
Fresenius Kabi AG
Profile
Michael Schönhofen is currently the President-Biopharma at Fresenius Kabi AG.
Previously, he worked as a Non-Executive Director at Fresenius Kabi Oncology Ltd. from 2008 to 2023.
He holds a doctorate degree from Technische Universität Darmstadt.
Michael Schönhofen active positions
| Companies | Position | Start |
|---|---|---|
Fresenius Kabi AG
 Fresenius Kabi AG BiotechnologyHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases | Corporate Officer/Principal | - |
Former positions of Michael Schönhofen
| Companies | Position | End |
|---|---|---|
| FRESENIUS KABI ONCOLOGY LTD | Chief Tech/Sci/R&D Officer | 13/01/2010 |
Training of Michael Schönhofen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
18
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Fresenius Kabi AG
Fresenius Kabi AG BiotechnologyHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases | Health Technology |
Technische Universität Darmstadt
 Technische Universität Darmstadt Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fresenius Kabi Oncology Ltd.
 Fresenius Kabi Oncology Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures and markets cancer research and anticancer products | Commercial Services |
- Stock Market
- Insiders
- Michael Schönhofen
